Irvin Chen

University of California, Los Angeles

Awards as PI

Funding
Disease Team Planning Stem Cell Therapy for AIDS- Disease Team Planning $52,500
SEED Grant Genetic modification of the human genome to resist HIV-1 infection and/or disease progression $642,652
Disease Team Research I HPSC based therapy for HIV disease using RNAi to CCR5. $9,905,604
Early Translational from Disease Team Conversion HPSC based therapy for HIV disease using RNAi to CCR5. $1,505,000
Total:
$12,105,756.00

Publications

© 2013 California Institute for Regenerative Medicine